active
ACTIVE SINCE: 2019
Back to Collaborations

Go Further: Partnership to End AIDS and Cervical Cancer

In 2019, our company joined the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the George W. Bush Institute (Bush Institute) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) in the Go Further: Partnership to End AIDS and Cervical Cancer among HIV-positive women in Africa.
SGDS CONTRIBUTING TO:
SHOW SUB-TARGETS + HIDE SUB-TARGETS -
MEMBER COMPANIES:
PARTNERING WITH:
SEE ALL PARTNER ORGANIZATIONS
Academia or research institute 1
Bilateral development organizations 1
Intergovernmental Organizations and Multilaterals 1

In 2019, MSD* joined PEPFAR, the George W. Bush Institute, and the Joint United Nations Programme on HIV/AIDS (UNAIDS) in the Go Further Partnership, an effort to reduce new cervical cancer cases by 95 percent among the estimated 3.8 million HIV-positive women who live in eight high-burden African countries. Human papillomavirus (HPV) is the major cause of cervical cancer, and women who are HIV-positive are four to five times more likely to develop invasive cervical cancer. Through this partnership, we are addressing cervical cancer in HIV-positive women in Sub-Saharan Africa, not only through screening and treatment, but also through prevention.

 

*MSD is known as Merck & Co., Inc. in the US & Canada

Quote
At Merck, we are committed to addressing the health care needs of women in the developing world and are pleased to support PEPFAR on this important initiative. Through this partnership we will be addressing HPV infection in a population most heavily impacted by HPV related cancer, not only through screening for and treating HPV, but also preventing it in the first place.
Kenneth C. Frazier
Chairman and chief executive officer, MSD
Results and milestones

As of March 30, 2020, the Go Further partnership has supported over 1 million cervical cancer screenings for women living with HIV, including 87% for whom it was a first-time screening, and treated over 50,000 women for pre-invasive cancerous lesions.

To address these risks, Go Further is increasing access to the human papillomavirus vaccine (HPV) to prevent cervical cancer, expanding the availability of vital cervical cancer screening, and providing treatment for women most vulnerable to developing cervical cancer. With minimal additional investment, these low-cost interventions can save millions of lives and help secure global gains against HIV/AIDS.

Geographic Reach
Disease Area
  • Infectious and Parasitic Disease
  • Women’s and Child Health
  • Non-communicable diseases
See Disease Areas
Target Population
  • Women
Partner organizations
Academia or research institute

George W. Bush Institute

Bilateral development organizations

US President's Emergency Plan for AIDS Relief (PEPFAR)

Intergovernmental Organizations and Multilaterals

UNAIDS

Geographic Reach

Africa

Disease Area

Infectious and Parasitic Disease

  • HIV/AIDS
    • Human Papillomavirus

      Women’s and Child Health

      • Women's Health

        Non-communicable diseases

        • Cancer
          • Cervical Cancer
        of